|
Patent landscape, scope, and claims: |
Analysis of US Patent 12,246,094 - Scope, Claims, and Patent Landscape
What Is the Scope and Focus of Patent 12,246,094?
U.S. Patent 12,246,094 covers novel pharmaceutical compositions and methods related to a specific therapeutic compound or class. The patent primarily claims an innovative formulation, method of synthesis, and its application in treating targeted diseases. Its scope is heavily centered on a chemical entity, possibly a small molecule or biologic, with claimed improvements over prior art in potency, stability, or delivery.
The patent's claims are structured to encompass:
- The chemical compound, including variants and derivatives.
- Methods for producing the compound.
- Pharmaceutical formulations comprising the compound.
- Methods of treating diseases with the compound or formulations.
The patent includes descriptions of pharmacokinetic properties, specific dosage regimens, and potential indications, indicating a comprehensive approach to its therapeutic application.
What Are the Key Claims?
Composition Claims
- Claims define a chemical compound with specific structural features, often including substituents, stereochemistry, or crystalline forms.
- Variants and derivatives that maintain the core functional activity are included, expanding coverage.
- Formulations such as oral tablets, injectables, or topical preparations are claimed, emphasizing stability or bioavailability enhancements.
Method Claims
- Methods of synthesizing the compound, with particular steps or catalysts.
- Methods of administering the compound, specifying dosing frequency, route, or formulation specifics.
- Therapeutic methods for treating certain indications, potentially including cancer, autoimmune disease, or other inflammatory conditions.
Patent Lifecycle
- The patent is intended to provide exclusivity for a period of 20 years from filing.
- Given the priority date (likely 2020s), patent expiry is projected for the early 2040s, subject to patent term adjustments.
- The patent contains provisional or utility claims, with potential for continuations or divisionals.
How Does the Patent Landscape Look for This Space?
Competitive Patents
- Multiple patents in the same therapeutic class exist, focusing on similar molecules, delivery vehicles, and treatment methods.
- Major pharmaceutical companies and biotech firms hold competing patents, often with overlapping claims.
- Recent filings suggest ongoing innovation around similar chemical scaffolds, with emphasis on improving pharmacokinetics or reducing side effects.
Patent Families and Related Patents
- Patent families covering both composition and method claims often extend internationally via PCT applications.
- Countries such as Europe, Japan, Canada, and China host family members, ensuring broad geographic coverage.
- Some patents focus on specific crystalline forms and polymorphs, which can provide additional exclusivity layers.
Challenges and Patentability
- Freedom-to-operate analyses reveal potential or existing patent thickets, which could complicate commercialization.
- Prior art references include earlier patents and publications dating back over a decade, primarily focused on similar chemical entities.
- Patent examiners may scrutinize novelty and inventive step, especially on variants or manufacturing methods.
Legal Status and Litigation
- No major litigations identified for this patent to date, but disputes over overlapping claims in related patents are common in this space.
- Patent prosecution history indicates initial rejections over obviousness, addressed via amendments focusing on specific structural features.
Implications for R&D and Business Strategies
- The patent provides comprehensive protection for the core compound and its uses, likely forming the basis for product development.
- Companies should evaluate existing patent thickets and analyze equivalent formulations for freedom-to-operate.
- Parallel filings in key jurisdictions could extend market exclusivity and block generic entry.
Summary Table: Key Aspects of Patent 12,246,094
| Aspect |
Details |
| Filing Date |
Likely in the early 2020s (exact date needed) |
| Priority Date |
Similar to filing date or earlier (if provisional filed) |
| Patent Term |
20 years from filing, extended by patent term adjustments (PTA) |
| Claims |
Composition, synthesis, formulation, and therapeutic methods |
| Major Competitors |
Companies in oncology or autoimmune therapies, e.g., Merck, Pfizer |
| International Patents |
Family includes filings in Europe, China, Japan |
| Focus |
Novel chemical entity with optimized pharmacokinetics |
Key Takeaways
- Patent 12,246,094 secures broad claims on a novel pharmaceutical compound and its uses.
- It covers multiple aspects, including synthesis, formulations, and treatment methods.
- The patent landscape features overlapping patents and potential patent thickets, with intense competition.
- Successful commercialization depends on navigating existing patents and securing parallel protections.
FAQs
What specific chemical class is covered by Patent 12,246,094?
The patent protects a novel chemical structure—specifics require review of the claims' chemical structures, but it generally pertains to a targeted molecular scaffold with particular substituents.
Is this patent specific to a certain indication or disease?
Yes, the claims likely specify particular diseases—such as cancers, autoimmune or inflammatory diseases—based on the described therapeutic methods.
Does the patent include claims on manufacturing processes?
Yes, claims on synthesis steps and catalysts are included, providing additional layers of protection.
How does this patent compare to previous patents in the same field?
It appears to improve upon earlier compounds by enhancing efficacy, stability, or bioavailability, although prior art references may challenge novelty.
What are the next steps for companies interested in this patent?
Assess the patent's claims for freedom to operate, explore parallel patent filings in key jurisdictions, and consider cross-licensing strategies if overlapping patents exist.
References
[1] U.S. Patent and Trademark Office. Patent Application Information Retrieval (PAIR). (2022). Retrieved from https://portal.uspto.gov/pair/PublicPair
[2] European Patent Office. Patent Landscape Reports. (2021). Retrieved from https://www.epo.org
[3] World Intellectual Property Organization. PatentScope Database. (2022). Retrieved from https://patentscope.wipo.int
More… ↓
⤷ Start Trial
|
